Refactor Capital — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
TL BiolabsMay 2018SEC filingmedium confidence
Santa Clara, US
Fred Turner(Executive Officer, Director)
Board seatZal Bilimoria· per SEC Form D · $7.5M raise · filed May 2018
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.